✦ LIBER ✦

Alkylating agents and cancer therapy

✍ Scribed by Ralhan, Ranju; Kaur, Jatinder

Book ID: 121248220
Publisher: Informa plc
Year: 2007
Tongue: English
Weight: 287 KB
Volume: 17
Category: Article
ISSN: 1354-3776
DOI: 10.1517/13543776.17.9.1061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Ralhan, Ranju; Kaur, Jatinder 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 287 KB

Double alkylating agent therapy with ifo

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group

✍ Nick Thatcher; David B. Smith; Mike J. Lind; Heather Anderson; Joyce Barclay; Ma 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Oral Alkylating Agents for Breast Cancer

Oral Alkylating Agents for Breast Cancer Therapy

✍ Dr Joyce Ann O’Shaughnessy 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 210 KB

Alkylating agents associated with lung c

Alkylating agents associated with lung cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Therapy-related leukemia associated with

✍ Davies, Stella M. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract The leukemogenic potential of alkylating agents has been known for many years and almost all alkylating agents in clinical use have been shown to increase the risk of leukemia. With these drugs the risk of leukemia appears to increase with increasing patient age, as does the risk of de

Acute Leukemia after Alkylating-Agent Th

Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer

✍ Reimer, Ronald R.; Hoover, Robert; Fraumeni, Joseph F.; Young, Robert C. 📂 Article 📅 1977 🏛 Massachusetts Medical Society 🌐 English ⚖ 905 KB